Clinical Trial Update: Cyclophosphamide, Fludarabine, and High-Dose Interleukin-2 in Treating Patients With Metastatic Melanoma [Phase 2]

View source ↗

Summary

This Phase 2 trial assessed a combination of cyclophosphamide, fludarabine, and high-dose interleukin-2 in metastatic melanoma; the study is completed and resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Fludarabine (Fludarabine)
• Interleukin-2 (high-dose) (Interleukin-2)

Snippet

Sponsor: Dartmouth-Hitchcock Medical Center | Conditions: Melanoma (Skin) | Phase 2 | Status: COMPLETED | Results posted: 2013-04-10